rs41302885
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_004415.4(DSP):c.6208G>A(p.Asp2070Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00425 in 1,614,150 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D2070H) has been classified as Uncertain significance.
Frequency
Consequence
NM_004415.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.6208G>A | p.Asp2070Asn | missense_variant | 24/24 | ENST00000379802.8 | |
DSP | NM_001319034.2 | c.4879G>A | p.Asp1627Asn | missense_variant | 24/24 | ||
DSP | NM_001008844.3 | c.4411G>A | p.Asp1471Asn | missense_variant | 24/24 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.6208G>A | p.Asp2070Asn | missense_variant | 24/24 | 1 | NM_004415.4 | P2 | |
DSP | ENST00000418664.2 | c.4411G>A | p.Asp1471Asn | missense_variant | 24/24 | 1 | A2 | ||
DSP | ENST00000710359.1 | c.4879G>A | p.Asp1627Asn | missense_variant | 24/24 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.00430 AC: 654AN: 152156Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00410 AC: 1027AN: 250724Hom.: 3 AF XY: 0.00414 AC XY: 561AN XY: 135608
GnomAD4 exome AF: 0.00424 AC: 6201AN: 1461876Hom.: 25 Cov.: 32 AF XY: 0.00432 AC XY: 3143AN XY: 727236
GnomAD4 genome ? AF: 0.00429 AC: 654AN: 152274Hom.: 4 Cov.: 32 AF XY: 0.00436 AC XY: 325AN XY: 74464
ClinVar
Submissions by phenotype
not provided Benign:8
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Sep 29, 2015 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jun 24, 2013 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 14, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 23, 2019 | This variant is associated with the following publications: (PMID: 25661095, 26073755, 26743238, 26498160, 24503780, 30972196, 31028937, 33232181) - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | DSP: BS2 - |
not specified Uncertain:1Benign:6
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Mar 26, 2014 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. Given the information regarding prevalence in the control population, it is likely this variant is too common to contribute significantly to disease. There are no publications associating this variant with ARVC. The ARVC variant database lists this variant as ‘nonpathogenic’ (http://www.arvcdatabase.info). This is a semi conservative amino acid change with a negatively charged aspartic acid replaced with a neutral asparagine. Aspartic acid is semi conserved at residue 2070 in the DSP gene. In silico analysis (PolyPhen 2) predicts the amino acid change to be probably damaging to protein structure/function. There are no reported missense variants in nearby residues. In total the variant has been seen in 46 of 7,160 laboratory controls, published controls and individuals from publicly available population datasets. This variant is found in 39 of 4,280 (0.91%) European American individuals and 4 of 2,201 (0.81%) African American individuals listed in the NHLBI Exome Sequencing Project dataset, which currently includes variant calls on ~6,500 Caucasian and African American individuals (as of 11/26/13). This variant is listed in dbSNP (rs41302885). Kapplinger et al (2011) did not observe the variant in 427 presumably healthy individuals that they studied. - |
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 24, 2015 | p.Asp2070Asn in exon 24 of DSP: This variant is not expected to have clinical si gnificance because it has been identified in 0.6% (393/65968) of European chromo somes, including 2 homozygotes, by the Exome Aggregation Consortium (ExAC, http: //exac.broadinstitute.org; dbSNP rs41302885). - |
Likely benign, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 22, 2020 | The heterozygous p.Asp2070Asn variant in DSP has been reported in 1 individual with arrhythmogenic cardiomyopathy (ACM), 2 with dilated cardiomyopathy (DCM), 1 with idiopathic ventricular fibrillation, and 1 suspected to have a genetic cardiovascular disease (PMID: 30820396, 25661095, 24503780, 26743238), and has been identified in 0.7910% (82/10366) of Ashkenazi Jewish chromosomes, 0.5636% (725/128630) of European (non-Finnish) chromosomes, and 0.5166% (183/35426) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs41302885). At least 3 affected individuals with this variant have an alternative molecular basis for DCM or ACM, suggesting that this variant may not be pathogenic (PMID: 24503780, 30820396; Variation ID: 45063). This variant has also been reported as benign, likely benign, and a VUS in ClinVar (Variation ID: 44936). The Aspartate (Asp) at position 2070 is highly conserved in mammals and evolutionary distant species, but one mammal (Wallaby) carries a Asparagine (Asn), supporting that this change at this position may be tolerated. Additional computational prediction tools do not provide strong support for or against an impact to the protein. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely benign. ACMG/AMP Criteria applied: BS1, BP5 (Richards 2015). - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | Mar 30, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 01, 2014 | - - |
Arrhythmogenic right ventricular dysplasia 8 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Uncertain significance, no assertion criteria provided | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Jun 04, 2015 | - - |
Cardiomyopathy Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Mar 08, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jan 29, 2018 | - - |
Primary dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Genetics and Genomics Program, Sidra Medicine | - | - - |
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Lethal acantholytic epidermolysis bullosa Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Woolly hair-skin fragility syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 21, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
DSP-related condition Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 30, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at